Loading... 2 0 5 0 false
Full Name
Pavkovikj, Marica
Variants
Pavkovic, Marica
 
Main Affiliation
 
Email
marica.pavkovic@medf.ukim.edu.mk
 
Other emails
 
Loading... 3 0 5 0 false

Publications
(Articles)

Results 21-40 of 60 (Search time: 0.003 seconds).

ПрегледНасловАвтор(ите)Датум на издавањеТип
21Current status in management of patients with chronic lymphocytic leukemia (CLL) in Republic of MacedoniaPavkovic, Marica ; Sonja Genadieva Stavric ; Gazmend Amzai ; Tatjana Sotirova ; Lidija Cevreska; Svetlana Stankovic ; Aleksandar Stojanovicјан-2016Article
22Cytotoxic T-Lymphocyte antigen-4 gene polymorphism is not associated with increased risk for chronic lymphocytic leukemia in Macedonian population.Arangelovic E; Pavkovic M ; Angelovic R; Trajkova S ; Trpkovska-Terzieva S; Panovska Stavridis I ; Genadieva-Stivric S ; Stojanovic A2019Proceeding article
23Evaluation of telomerase activity in patients with chronic B lymphocytic leukemia versus age matched controls. Correlation between telomerase activity and bone marrow infiltrationJovanovic R ; Petrusevska G ; Cevreska L ; Stojanovic A; Janevska V ; Kostadinova Kunovska S ; Pavkovikj, Marica 2007Article
24FC gamma receptor polymorphisms in patients with immune thrombocytopeniaMarica Pavkovic ; Aleksandar Petlichkovski ; Oliver Karanfilski ; Lidija Cevreska ; Aleksandar Stojanovicапр-2018Article
25FCGR2A and FCGR3A polymorphisms and response to rituximab treatment in patients with B-cell chronic lymphocytic leukemia.Angelovic R; Pavkovic M ; Panovska Stavridis I ; Arangelovic E; Trajkova S ; Cadievski L; Stojanovic A2019Proceeding article
26Genetic variation in platelet glycoprotein receptor GP IIIa and GP Ia are not associated with diabetic retinopathy in type 2 diabetes mellitus.Pavkovic M ; Laban-Guceva N; Percan V; Dimitrovski C; Spiroski M 2005Proceeding article
27The gold standard for treating Hodgkin`s disease patients: Where does ABVD acquire its evident superiority?O. Karanfilski ; S. Stankovic ; T. Sotirova ; M. Pavkovic ; S. Trajkova ; A. Stojanovic2005Proceeding article
28Granulocytic-colono stimulating factor (Neupogen) in improving of myocardial hemodinamic function in patients treated with chemotherapyL. Cevreska ; D. Efremov; S. Genadieva Stavric ; M. Ivanovski; N. Siljanovski; M. Pavkovic ; S. Stankovic 2003Proceeding article
29Immune thrombocytopenic purpura in adults in the last 10 years: single-centre experiencePavkovic M ; Trpkovska-Terzieva S; Sotirova T ; Latifi A; Cevreska L ; Stojanovic A2012Article
30Immunoglobulin classes (IgA, IgG, IgM) in serum of rats during acclimation to elevated ambient temperature.Jurhar-Pavlova, M ; Trajkov, D ; Pavkovic, M ; Petlichkovski, A ; Arsov T; Jankova, R ; Dinevska-Kjovkarova S; Mitova B; Mitev S; Spiroski, M 2001Proceeding article
31Immunosupressive treatment with cyclosporin-A for a patient with hypoplastic myelodisplastic syndrome: a case reportPavkovic M ; Jovanovic R ; Petrusevska G ; Cevreska L ; Stojanovic A2011Article
32INFLUENCE OF PROGNOSTIC FACTORS ON OVERALL SURVIVAL IN MYELODYSPLASTIC SYNDROMESSotirova, Tatjana ; Stojanovikj, Aleksandar ; Genadieva stavrikj, Sonja ; Karanfilski, Oliver ; Krstevska balkanov, Svetlana ; Pavkovikj, Marica ; Trpkovska Terzieva, Slobodanka2015Proceeding article
33LONG-TERM FOLLOW-UP OF ADULT PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA AFTER SPLENECTOMYPavkovic M ; Trpkovska-Terzieva S; Latifi A; Karanfilski O ; Cevreska L ; Stojanovic Aсеп-2011Article
34LOW FREQUENCY OF CLONAL B CELL EXPANSIONS IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURAPavkovic, M ; Efremov D1-јан-2021Article
35MAINTENANCE THERAPY WITH RITUXIMAB IN ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIAPavkovic M ; Trpkovska-Terzieva S; Sotirova T ; Cevreska L ; Stojanovic A15-мар-2013Article
36Molecular methods in the diagnosis of the myeloproliferative neoplasms-single centre experience.Angelovic R; Pavkovic M ; Georgievski B ; Stojanovic A; Cevreska L ; Arangelovic E; Gjorgoski I; Mladenov M2015Proceeding article
37Molecular monitoring and BCR-ABL gene mutations in Imatinib resistant CML patients in our centre.Pavkovic M ; Plasevska-Karanfilska D; Angelovic R; Angelkovic E; Genadieva-Stivric S ; Panovska Stavridis I ; Cevreska L ; Stojanovic A2019Proceeding article
38Molecular Response in Patients with Chronic Myeloid Leukemia Treated with Imatinib - Single Centre ExperiencePavkovic M ; Angelkovic R; Popova-Simjanovska M; Genadieva-Stavric S ; Cevreska L ; Stojanovic A2015Article
39Monitoring the safety of nilotinib in patients with chronic myeloid leukemiaPendovska M; Naumovska Z ; Panovska I; Pavkovic M ; Kalcev G; Zisovska E; Mihajloska E; Filkova S; Shuturkova, Lj 2019Article
40Monoclonal anti-CD20 antibodies (Mabthera) in the treatment of auto-immune hemolytic anemiaM. Pavkovic ; D.G. Efremov; B. Georgievski ; S. Stankovic ; S. Genadieva Stavric ; I. Panovska ; L. Cevreska 2003Proceeding article